Although it is unclear whether there is a difference between specific subtypes of breast tumors, trogocytosis has previously been shown to be attenuated when PI3K signaling was inhibited by using synthetic inhibitors such as Wortmannin (Hasim et al., 2022; Shin et al., 2021). Here, PIK3CA is linked to breast neoplasm.